Insulin secretion impairment induced by rosuvastatin partly though autophagy in INS‐1E cells
- 24 July 2019
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 44 (1) , 127-136
Abstract
Statins are used extensively for the clinical treatment of cardiovascular diseases. Recent studies suggest that statins increase the risk of new‐onset diabetes mellitus (NODM). However, the mechanisms of statin‐induced NODM remain unclear. The present study investigated the effects of autophagy on insulin secretion impairment induced by rosuvastatin (RS) in rat insulinoma cells (INS‐1E) cells. INS‐1E cells were cultured and treated with RS at different concentrations (0.2–20 μM) for 24 h. Insulin secretion in INS‐1E cells was detected by enzyme‐linked immunosorbent assay, and the co‐localization of microtubule‐associated protein light chain 3 (LC3) and lysosome‐associated membrane protein 2 (LAMP‐2) was observed by immunofluorescence staining. Western blotting was used to assess the conversion of LC3 and p62. The results showed that the insulin secretion and cell viability decrease induced by RS treatment for 24 h occurred in a dose‐dependent manner in INS‐1E cells. RS significantly inhibited the expression of LC3‐II but increased the protein expression of p62. Simultaneously, RS diminished the co‐localization of LC3‐II and LAMP‐2 fluorescence signals. These results suggested that RS‐inhibited autophagy in INS‐1E cells. Rapamycin, an autophagy agonist, reversed the insulin secretion and cell viability suppression induced by RS in INS‐1E cells. RS also decreased the phosphorylation of the mammalian target of rapamycin (mTOR). The results indicated that RS impairs insulin secretion in INS‐1E cells, which may be partly due to the inhibition of autophagy via an mTOR‐dependent pathway.Keywords
This publication has 37 references indexed in Scilit:
- New onset diabetes mellitus induced by statins: current evidencePostgraduate Medicine, 2017
- Statin treatment and new-onset diabetes: A review of proposed mechanismsMetabolism, 2014
- Stimulation of Autophagy Improves Endoplasmic Reticulum Stress–Induced DiabetesDiabetes, 2013
- High Passage MIN6 Cells Have Impaired Insulin Secretion with Impaired Glucose and Lipid OxidationPLOS ONE, 2012
- Role of mTOR in podocyte function and diabetic nephropathy in humans and miceJournal of Clinical Investigation, 2011
- The emerging role of autophagy in the pathophysiology of diabetes mellitusAutophagy, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Autophagy Is Important in Islet Homeostasis and Compensatory Increase of Beta Cell Mass in Response to High-Fat DietCell Metabolism, 2008
- Distinct Effects of Pravastatin, Atorvastatin, and Simvastatin on Insulin Secretion from a β-cell Line, MIN6 CellsJournal of Atherosclerosis and Thrombosis, 2006
- Safety of StatinsCirculation, 2004